According to the latest report by IMARC Group, titled “Non-Invasive Prenatal Testing (NIPT) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026,” the global non-invasive prenatal testing market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the global non-invasive prenatal testing market to grow at a CAGR of 10.70% during 2021-2026. Non-invasive prenatal testing (NIPT) is a test conducted on a pregnant woman to determine the baby’s chances of being born with some common chromosomal conditions. The test is conducted to diagnose genetic disorders, including Down syndrome, Edward syndrome, Patau syndrome, and Turner syndrome. This is mainly recommended for couples with a family history of genetic disorders. The procedure assists in differentiating between maternal and fetal DNA and can be performed after nine weeks of pregnancy.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Request Free Sample Report (Exclusive Offer on this report): https://www.imarcgroup.com/non-invasive-prenatal-testing-market/requestsample
Global Non-Invasive Prenatal Testing Market Trends:
The global market is majorly driven by the high risks of developing chromosomal abnormalities with the increasing maternal age. Along with this, the increasing public healthcare expenditure by the governments of several countries is offering significant growth opportunities to the key market players to develop advanced testing procedures and enhance their product availability. Furthermore, the increasing demand for ultrasound detection and biochemical screening tests is positively influencing the market growth. Besides this, rapid advancements in technologies to enhance testing capabilities is creating a positive outlook for the market. Additionally, the growing awareness regarding non-invasive prenatal testing and the increasing recommendation by obstetricians to opt for diagnostic screening in the first trimester of pregnancy are also providing a thrust to the market growth.
Ask Analyst for Instant Discount and Download Full Report with TOC & List of Figure: https://www.imarcgroup.com/non-invasive-prenatal-testing-market
Non-Invasive Prenatal Testing Market 2021-2026 Analysis and Segmentation:
- Agilent Technologies Inc.
- Berry Genetics Inc.
- BGI Genomics Co. Ltd.
- Eurofins LifeCodexx GmbH
- F. Hoffmann-La Roche AG
- GE Healthcare, Igenomix
- Illumina Inc.
- Laboratory Corporation
- Natera Inc.
- Perkinelmer Inc.
- Thermo Fisher Scientific Inc.
- Yourgene Health
Breakup by Product Type:
Breakup by Test Type:
- Materni 21
Breakup by Technology:
Breakup by Test Type:
- Ultrasound Detection
- Biochemical Screening Tests
- Cell-Free DNA in Maternal Plasma Tests
- Fetal Cells in Maternal Blood Tests
Breakup by Application:
- Microdeletions Syndrome
Breakup by End-User:
- Diagnostic Laboratories
Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (Germany, France, United Kingdom, Italy, Spain, Others)
- Europe (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key highlights of the Report:
- Market Performance (2015-2020)
- Market Outlook (2021-2026)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800